This study will conduct a single-center clinical trial to explore the initial therapeutic effect of ginkgo biloba dropping pills, huperzine A injection and median nerve electrical stimulation in patients with cognitive impairment.
Be over 18 years old
Residual cognitive impairment due to brain injury
No previous history of brain-related diseases except this one
The patient had severe underlying disease and unstable vital signs
The patient was complicated with consciousness disorder and could not cooperate with cognitive function assessment ③ Allergic to drugs or contraindications in drug use ④ There are contraindications of median nerve electrical stimulation
Wanbangde Pharmaceutical Group Co., LTD
Lead sponsor
Ganzhou City People's Hospital
Collaborator